Arrowhead Gold Corp.

• Arrowhead Gold kauft Nuvo Energy Grid Inc.

  Arrowhead Gold Corp. gab am Freitag die Unterzeichnung einer Absichtserklärung bekannt, wonach Arrowhead 100% der ausstehenden Aktien von Nuvo Energy Grid Inc. übernehmen wird. Bei Nuvo Energy handelt es sich um ein Privatunternehmen mit Hauptsitz im kanadischen Toronto. Gemäß Plan wird Arrowhead alle Aktien von Nuvo erwerben und den Nuvo-Aktionären dafür 13,25 Mio. Stammaktien von Arrowhead (nach Konsolidierung [...]

  weiterlesen

  19.10.2015

  von Redaktion
• Arrowhead Gold Corp. kauft Bio Therapeutic Molecules Inc.

  Arrowhead Gold meldete gestern, dass man sich der geplanten Übernahme des kanadischen Unternehmens Bio Therapeutic Molecules Inc. nähere. Wie im März bekanntgegeben wurde, soll Arrowhead alle Aktien von Bio Therapeutic Molecules im Tausch gegen 41,5 Mio. Arrowhead-Stammaktien erwerben. Vor Abschluss der Transaktion müssen jedoch noch einige Bedingungen erfüllt werden, wie. z.B. der Abschluss einer Finanzierung. Nach [...]

  weiterlesen

  19.06.2015

  von Redaktion

weitere Meldungen

• Arrowhead Gold Corp. to Acquire Nuvo Energy Grid Inc.

  Arrowhead Gold is pleased to announce that it has signed a Letter of Intent (LOI) to acquire 100% of the outstanding shares of Nuvo Energy Grid Inc., a private company, with its headquarters in Toronto. Pursuant to the LOI, Arrowhead will acquire all shares of Nuvo from the Nuvo shareholders in exchange for 13.25 million post consolidated common shares of Arrowhead. Nuvo has sufficient working capital to develop its [...]

  weiterlesen

  16.10.2015

  von Marketwire
• Arrowhead Gold to Sign Definitive Agreement to Acquire Bio Therapeutic Molecules Inc.

  Arrowhead Gold is pleased to announce, as per its news release of March 15, 2015, that it is moving forward with a definitive agreement to acquire 100% of the outstanding shares of Bio Therapeutic Molecules, a private company, with its headquarters in Guelph, Ontario. Pursuant to the Agreement, Arrowhead will acquire all shares of BTMI from the BTMI shareholders in exchange for 41.5 million common shares of [...]

  weiterlesen

  18.06.2015

  von Marketwire
• Arrowhead Gold to Acquire Bio Therapeutic Molecules Inc.

  Arrowhead Gold is pleased to announce that it has signed a Letter of Intent to acquire 100% of the outstanding shares of Bio Therapeutic Molecules, a private company, with its headquarters in Guelph, Ontario. Pursuant to the LOI, Arrowhead will acquire all shares of BTMI from the BTMI shareholders in exchange for 41.5 million common shares of Arrowhead, providing both AWH and BTMI are satisfied with due diligence to [...]

  weiterlesen

  12.03.2015

  von Marketwire
• Arrowhead Commences Trading on the Canadian Securities Exchange, Undertakes Shares for Debt Settlement and Announces Unit Private Placement

  Arrowhead Gold announces that further to the Company's news release dated October 24, 2014, the Company delisted its common shares from the TSX Venture Exchange at the close of business day on October 29, 2014 and will commence trading its common shares on the Canadian Securities Exchange on October 30, 2014. The Company's name and trading symbol will remain the same.

  weiterlesen

  30.10.2014

  von Marketwire
• CORRECTION FROM SOURCE: Arrowhead to Evaluate Agricultural, Pharmaceutical, Medical Technology and Resource Opportunities and Announces Financing

  This release corrects and replaces the version that was disseminated at 11:42 AM ET today. The gross proceeds amount was incorrect and has been corrected to read $640,000. Arrowhead Gold announces that it will be investigating additional company growth prospects. The new areas that will be examined will potentially include, but will not be limited to, agriculture, pharmaceutical, medical technology, and resources. At [...]

  weiterlesen

  09.04.2014

  von Marketwire

weitere engl. Meldungen